Posts Archive


Top Five Takeaways From a Deep Dive Into Obviousness at the PTAB

Since the America Invents Act ushered in a series of sweeping changes to the U.S. patent system in 2011, IP stakeholders have been grappling with Inter Partes …
By John Abramic
8 days ago 4

Other Barks & Bites for Friday, March 15: Final Notice on USPTO MTA Practice, Boalick Appointed Chief PTAB Judge, and More

This week in Other Barks & Bites: the U.S. Patent and Trademark Office promotes Scott Boalick to Chief Judge of the Patent Trial and Appeal Board (PTAB); …
By IPWatchdog
8 days ago 4

Examining the USPTO’s First Precedential Opinion Panel Decision

The first decision issued by the new USPTO Precedential Opinion Panel (POP) tackled the difficult issues of statutory interpretation of sections 35 U.S.C. § 315(b) and 35 U.…
By Russell Slifer
9 days ago 3

USPTO Precedential Opinion Panel Delivers Lukewarm Attempt to Streamline PTAB Policy

In September 2018, the United States Patent and Trademark Office (USPTO) announced the substantial revision of Standard Operating Procedures (SOPs) for the paneling of matters before the Patent …
By IPWatchdog
9 days ago 0

In Memory: Farewell to Senator Birch Bayh

On Wednesday, March 14, we lost Senator Birch Bayh.  We knew for several months that this day wasn't far off, as his health rapidly declined.  I wanted to …
By Joseph Allen
9 days ago 5

Don’t Give Up: Section 101 Allowances Are Up at USPTO

The data shows that Section 101 allowances at the USPTO are on the rise after a long period of decline, but the 101 situation still remains “alarming,” said panelists …
By Eileen McDermott
9 days ago 2

Why Huawei is Unlikely to Win Its Case Against the United States

In an expected move, Huawei filed a lawsuit against the United States in the U.S. District Court for the District of Texas on March 6. Huawei Technologies …
By Cameron Tousi
10 days ago 2

Up and Running: Senate IP Subcommittee Debates USPTO Oversight After Setting Ambitious Agenda in February

Today, March 13, the Senate Subcommittee on Intellectual Property met to discuss “Oversight of the United States Patent and Trademark Office,” with USPTO Director Andrei Iancu as the …
By IPWatchdog
10 days ago 2

House Health Subcommittee Holds Fractious Hearing on Drug Pricing and Patent Protections

On the morning of Thursday, March 7, the House Ways & Means Committee’s Subcommittee on Health held a hearing titled Promoting Competition to Lower Medicare Drug Prices. The …
By Steve Brachmann
11 days ago 16

EPO Patent Applications Grow By 4.6% to Reach New High

There were 174,317 patent applications filed at the European Patent Office in 2018, according to figures in its Annual Report published today (March 12). That represents an increase of 4.6% on 2017, …
By James Nurton
11 days ago 1

New Study Shows Bayh-Dole is Working as Intended—and the Critics Howl

Just as the drug pricing debate on Capitol Hill is heating up, an important new study, "The Bayh-Dole Act's Vital Importance to the U.S. Life-Sciences Innovation …
By Joseph Allen
11 days ago 0

EFF Trolls the Patent Office with ‘Save Alice Campaign’

The Electronic Frontier Foundation (EFF) is at it again, this time with what they refer to as a Save Alice campaign. The EFF does not like the …
By Gene Quinn
12 days ago 22

IP and Innovation on Capitol Hill: Week of March 11

This week on Capitol Hill, both houses of Congress are abuzz with a full schedule of hearings related to science, technology and innovation topics. In the House …
By IPWatchdog
12 days ago 1

Sounds Fishy: Can Broadening Language Actually Be Limiting?

In a previous essay, I discussed a U.S. Supreme Court case that had nothing to do with patent law, but that patent practitioners may wish to …
By Daniel Hanson
12 days ago 1

Post-Myriad Legal and Policy Considerations for Patenting Genetic Inventions

The U.S. Supreme Court’s 2013 ruling in Association for Molecular Pathology v. Myriad Genetics changed the landscape of what is considered patentable material in the context …